Literature DB >> 20218136

Injection prescribing patterns in public health care facilities in Egypt.

C Bodenschatz1, M Talaat, A Kandeel, A L Lohiniva, E Radwan, F Mahoney.   

Abstract

This study assessed the frequency of and rationale for use of injections at health care facilities in Egypt based on WHO core drug use indicators. We reviewed 1406 prescriptions in 43 randomly selected hospitals and primary health care clinics in 2 governorates in Upper and Lower Egypt in 2001. Patients received an injection at 18.1% of encounters. The most frequently prescribed parenteral drugs were anti-infectives (56.9% of injections) and analgesics (13.7%). Injections were more often prescribed in hospitals than in primary health care clinics and in rural than in urban settings. Most injections (94.7%) could have been replaced by a suitable oral preparation. Further efforts are needed to enforce the essential medicines programme in Egypt to improve rational drug prescribing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20218136

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  3 in total

1.  Prescribing practices of physicians at different health care institutions.

Authors:  Salih Mollahaliloglu; Ali Alkan; Basak Donertas; Senay Ozgulcu; Ahmet Akici
Journal:  Eurasian J Med       Date:  2013-06

2.  Relationship Between the Provision of Injection Services in Ambulatory Physician Offices and Prescribing Injectable Medicines.

Authors:  Naeimeh Yousefi; Arash Rashidian; Fatemeh Soleymani; Abbas Kebriaeezade
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

3.  Incidence and etiology of hospitalized acute respiratory infections in the Egyptian Delta.

Authors:  Emily Rowlinson; Erica Dueger; Adel Mansour; Nahed Azzazy; Hoda Mansour; Lisa Peters; Summer Rosenstock; Sarah Hamid; Mayar M Said; Mohamed Geneidy; Monier Abd Allah; Amr Kandeel
Journal:  Influenza Other Respir Viruses       Date:  2016-08-12       Impact factor: 4.380

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.